Abstract
Apathy is a behavioural disturbance occurring alone or in concomitance with depression in Parkinson’s disease (PD). Here we present a validation study for the self-report version of the Apathy Evaluation Scale (AES-S), carried out in a sample of 60 non-demented, non-depressed untreated, drug-naïve, de novo PD patients; 20 patients of the sample (33.3 %) were classified as apathetic according to current clinical criteria. All enrolled patients completed the AES-S and a neurological and cognitive assessment. Mean AES-S score was 34.43. AES-S did not show floor or ceiling effect. Cronbach’s alpha was 0.872. Principal component analysis revealed three factors: the first (34.4 % of the variance) represented constitutive aspects of the construct of apathy; the second (8.5 % of the variance) represented a social dimension; the third factor (7.9 % of the variance) represented a dimension related to insight. With respect to clinical criteria for apathy considered as the gold standard, receiver operating characteristics curve analysis showed that a cut-off of 36/37 has the maximum discrimination power. High sensitivity and negative predictive values were obtained with cut-off scores of 33/34 or lower; high specificity and positive predictive values were obtained with cut-off scores of 38/39 or higher. AES-S score correlated with scores on frontal tasks, but not on Beck Depression Inventory, Unified Parkinson’s Disease Rating Scale, Hoehn and Yahr scale. The AES-S is a reliable and valid questionnaire for detecting apathy in PD. For screening purposes a 33/34 cut-off score is indicated, but a 38/39 cut-off score is necessary when a high specificity is desired.
Similar content being viewed by others
References
Marin RS (1991) Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 3:243–754
Pedersen KF, Larsen JP, Alves G, Aarsland D (2009) Prevalence and clinical correlates of apathy in Parkinson’s disease: a community-based study. Parkinsonism Relat Disord 15:295–299
Pluck GC, Brown RG (2002) Apathy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 73:636–642
Grossi D, Santangelo G, Barbarulo AM et al (2013) Apathy and related executive syndromes in dementia associated with Parkinson’s disease and in Alzheimer’s disease. Behav Neurol 27:515–522. doi:10.3233/BEN-129023
Lj Ziropadja, Stefanova E, Petrovic M, Stojkovic T, Kostic VS (2012) Apathy and depression in Parkinson’s disease: the Belgrade PD study report. Parkinsonism Relat Disord 18:339–342
Cubo E, Benito-León J, Coronell C, Armesto D, ANIMO Study Group (2012) Clinical correlates of apathy in patients recently diagnosed with Parkinson’s disease: the ANIMO study. Neuroepidemiology 38:48–55
Pedersen KF, Alves G, Brønnick K, Aarsland D, Tysnes OB, Larsen JP (2010) Apathy in drug-naïve patients with incident Parkinson’s disease: the Norwegian ParkWest study. J Neurol 257:217–223
Santangelo G, Vitale C, Trojano L et al (2012) Neuropsychological correlates of theory of mind in patients with early Parkinson’s disease. Mov Disord 27:98–105
Varanese S, Perfetti B, Ghilardi MF, Di Rocco A (2011) Apathy, but not depression, reflects inefficient cognitive strategies in Parkinson’s disease. PLoS ONE 6:e17846
Dujardin K, Sockeel P, Delliaux M, Destée A, Defebvre L (2009) Apathy may herald cognitive decline and dementia in Parkinson’s disease. Mov Disord 24:2391–2397
Martínez-Horta S, Pagonabarraga J, Fernández de Bobadilla R, García-Sanchez C, Kulisevsky J (2013) Apathy in Parkinson’s disease: more than just executive dysfunction. J Int Neuropsychol Soc 19:571–582
Santangelo G, Vitale C, Trojano L et al (2009) Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia. J Neurol 256:632–638
Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG (1992) Reliability, validity, and clinical correlates of apathy in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 4:134–913
Zgaljardic DJ, Borod JC, Foldi NS et al (2007) Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease. Cogn Behav Neurol 20:184–192
Butterfield LC, Cimino CR, Oelke LE, Hauser RA, Sanchez-Ramos J (2010) The independent influence of apathy and depression on cognitive functioning in Parkinson’s disease. Neuropsychology 24:721–730
Santangelo G, Morgante L, Savica R, Marconi R, Grasso L, Antonini A, De Gaspari D, Ottaviani D, Tiple D, Simoni L, Barone P, PRIAMO Study Group (2009) Anhedonia and cognitive impairment in Parkinson’s disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study. Parkinsonism Relat Disord 15:576–581
Benito-León J, Cubo E, Coronell C, ANIMO Study Group (2012) Impact of apathy on health-related quality of life in recently diagnosed Parkinson’s disease: the ANIMO study. Mov Disord 27:211–218
Santangelo G, Vitale C, Trojano L, Picillo M, Moccia M, Pisano G, Pezzella D, Cuoco S, Erro R, Longo K, Pellecchia MT, Amboni M, De Rosa A, De Michele G, Barone P (2014) Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson’s disease: a prospective longitudinal study. Eur J Neurol. doi:10.1111/ene.12467
Santangelo G, Trojano L, Barone P, Errico D, Grossi D, Vitale C (2013) Apathy in Parkinson’s disease: diagnosis, neuropsychological correlates, pathophysiology and treatment. Behav Neurol 27:501–513. doi:10.3233/BEN-129025
Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, Weintraub D, Sampaio C, Poewe W, Rascol O, Stebbins GT, Goetz CG (2008) Apathy and anhedonia rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 23:2004–2014
Marin RS, Biedrzycki RC, Firinciogullari S (1991) Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 38:143–162
Kay DB, Kirsch-Darrow L, Zahodne LB, Okun MS, Bowers D (2012) Dimensions of apathy in Parkinson’s disease: exploratory factor analysis of the apathy scale. J Parkinsons Dis 2:161–166
Pedersen KF, Alves G, Larsen JP, Tysnes OB, Møller SG, Brønnick K (2012) Psychometric properties of the Starkstein Apathy Scale in patients with early untreated Parkinson disease. Am J Geriatr Psychiatry 20:142–148
Robert PH, Onyike CU, Leentjens AFG, Dujardin K, Aalten P, Starkstein SE et al (2009) Proposed diagnostic criteria for apathy in Alzheimer’s disease and other neuropsychiatric disorders. Eur Psychiatry 24:98–104
Drijgers RL, Dujardin K, Reijnders JS, Defebvre L, Leentjens AF (2010) Validation of diagnostic criteria for apathy in Parkinson’s disease. Parkinsonism Relat Disord 16:656–660
Levy R, Dubois B (2006) Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 16:916–928
McKinlay A, Grace RC, Dalrymple-Alford JC, Anderson TJ, Fink J, Roger D (2008) Neuropsychiatric problems in Parkinson’s disease: comparisons between self and caregiver report. Aging Ment Health 12:647–653
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. DSM-IV-TR, American Psychiatric Association, Washington
Emre M, Aarsland D, Brown R et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707
Santangelo G, Vitale C, Trojano L, De Gaspari D, Bilo L, Antonini A, Barone P (2010) Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions. Mov Disord 25:50–56
Folstein M, Folstein SE, McHugh PR (1975) Mini-Mental State: a practical method for grading the cognitive state of patients for the clinicians. J Psychiatr Res 12:189–198
Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E (1996) Trail making test: normative values from 287 normal adult controls. Ital J Neurol Sci 17:305–309
Barbarotto R, Laiacona M, Frosio R et al (1998) A normative study on visual reaction times and two Stroop colour-word tests. Ital J Neurol Sci 19:161–170
Appollonio I, Leone M, Isella V, Piamarta F, Consoli T, Villa ML, Forapani E, Russo A, Nichelli P (2005) The frontal assessment battery (FAB): normative values in an Italian population sample. Neurol Sci 26:108–116
Visser M, Leentjens AF, Marinus J, Stiggelbout AM, van Hilten JJ (2006) Reliability and validity of the Beck depression inventory in patients with Parkinson’s disease. Mov Disord 21:668–672
Isella V, Appollonio I, Meregalli L, Melzi P, Iurlaro S, Frattola L (1998) Dati normativi per le versioni italiane delle scale di apatia e di anedonia. Archivio di psicologia, neurologia e psichiatria 59:356–375
Fahn S, Elton RL (1987) Members of the UPDRS Development Committee. In: Fahn S, Marsden CD, Calne D, Goldstein M (eds) Recent developments in Parkinson’s disease. MacMillan, Florham Park, pp 153–304
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442
Hays RD, Anderson R, Revicki D (1993) Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 2:441–449
McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical practice: are available health surveys adequate? Qual Life Res 4:293–307
Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297–334
Scientific Advisory Committee of the Medical Outcomes Trust (2002) Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 11:193–205
Nunnally JC, Bernstein IH (1994) Psychometric theory. McGraw- Hill, New York
Wyrwich KW, Nienaber MA, Tierney WM, Wolinsky FD (1999) Linking clinical relevance and statistical significance in evaluating intraindividual changes in health-related quality of life. Med Care 37:469–478
Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW (1987) A measure of quality of life for clinical trials in chronic lung disease. Thorax 42:773–778
Juniper EF, Guyatt GH, Jaeschke R (1996) How to develop and validate a new health-related quality of life instrument. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Lippincott-Raven Publishers, Philadelphia, pp 49–56
Clarke DE, Rv Reekum, Simard M, Streiner DL, Freedman M, Conn D (2007) Apathy in dementia: an examination of the psychometric properties of the apathy evaluation scale. J Neuropsychiatry Clin Neurosci 19:57–64
Dujardin K, Sockeel P, Devos D, Delliaux M, Krystkowiak P, Destée A, Defebvre L (2007) Characteristics of apathy in Parkinson’s disease. Mov Disord 22:778–784
Stuss DT, Van Reekum R, Murphy KJ (2000) Differentiation of states and causes of apathy. In: Borod J (ed) The neuropsychology of emotion. Oxford University Press, New York, pp 340–363
Esposito F, Rochat L, Juillerat Van der Linden AC, Lekeu F, Charnallet A, Van der Linden M (2014) Apathy in aging: are lack of interest and lack of initiative dissociable? Arch Gerontol Geriatr 58:43–50
Stanton BR, Leigh PN, Howard RJ, Barker GJ, Brown RG (2013) Behavioural and emotional symptoms of apathy are associated with distinct patterns of brain atrophy in neurodegenerative disorders. J Neurol 260:2481–2490
Raimo S, Trojano L, Spitaleri D, Petretta V, Grossi D, Santangelo G. Apathy in Multiple Sclerosis: A validation study of the Apathy Evaluation Scale. J Neurol Sci
Kirsch-Darrow L, Fernandez HH, Marsiske M, Okun MS, Bowers D (2006) Dissociating apathy and depression in Parkinson disease. Neurology 67:33–38
Isella V, Melzi P, Grimaldi M, Iurlaro S, Piolti R, Ferrarese C, Frattola L, Appollonio I (2002) Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson’s disease. Mov Disord 17:366–371
Laatu S, Karrasch M, Martikainen K, Marttila R (2013) Apathy is associated with activities of daily living ability in Parkinson’s disease. Dement Geriatr Cogn Disord 35:249–255
Conflicts of interest
The authors declare that they have no conflict of interest.
Ethical standards
The present study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Santangelo, G., Barone, P., Cuoco, S. et al. Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale. J Neurol 261, 2319–2328 (2014). https://doi.org/10.1007/s00415-014-7498-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-014-7498-1